.jpg?format=webp&width=780)
Industry funding and corporate sponsorship have played a significant role in advancing orthopaedic research and technology. However, this relationship raises concerns about how industry associations may bias research findings and influence clinical practice. To determine whether industry affiliation plays a role in randomized controlled trials (RCTs) outcomes investigating platelet-rich plasma (PRP). The study's results demonstrated that qualitative conclusions and outcome scores were not associated with industry affiliation. Although the results of this study suggest that there is no influence of industry involvement on RCTs examining PRP, it is still necessary to carefully evaluate relevant commercial affiliations when reviewing recommendations from studies before adopting new treatment approaches, such as the use of PRP for knee osteoarthritis.
Like
Save
Share